| Literature DB >> 20550926 |
Abstract
The ever-decreasing cost of sequencing is ushering in a new era in genomic medicine. Laura Bonetta reports on new studies that provide a glimpse of the opportunities ahead. Copyright 2010 Elsevier Inc. All rights reserved.Mesh:
Year: 2010 PMID: 20550926 DOI: 10.1016/j.cell.2010.05.034
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582